Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Isabel Virella-Lowell
Professor
Close
E-mail
ilowell@peds.uab.edu
ilowell@uab.edu
Phone
205-638-9583
Links
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Isabel Virella-Lowell
Professor
Positions
Scientist (C)
,
Cystic Fibrosis Research Center
,
School of Medicine
Senior Scientist (C)
,
Center for Clinical and Translational Science (CCTS)
,
General Clinical Research Center
Professor (P)
,
Pediatric - Pulmonary & Sleep Medicine
,
Pediatrics
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2018
Age-related heterogeneity in dental caries and associated risk factors in individuals with cystic fibrosis ages 6–20 years: A pilot study
.
Journal of Cystic Fibrosis
. 17:747-759.
2018
2018
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis
.
Pediatric Pulmonology
. 53:E21-E23.
2018
2016
Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study
.
Current Medical Research and Opinion
. 32:1789-1795.
2016
2015
Quantitative sinonasal symptom assessment in an unselected pediatric population with cystic fibrosis
2015
2010
IL-10 delivery by AAV5 vector attenuates inflammation in mice with pseudomonas pneumonia
2010
2009
Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis
.
American Journal of Respiratory Cell and Molecular Biology
. 41:367-375.
2009
2009
Cost-effective airway cultures in the cystic fibrosis patient
2009
2008
Oral instillation with surfactant phospholipid: A reliable alternative to intratracheal injection in mouse studies
.
Laboratory Animals
. 42:294-304.
2008
2005
Enhancing rAAV vector expression in the lung
.
Journal of Gene Medicine
. 7:842-850.
2005
2005
Emergency preparedness for the chronically ill
.
American Journal of Nursing
. 105:68-72.
2005
2004
Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line
.
Molecular Therapy
. 10:562-573.
2004
2002
Adeno-associated viral vectors for CF gene therapy.
.
Methods in Molecular Medicine
. 70:599-608.
2002
2000
Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients
2000
1997
Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls
.
Clinical immunology and immunopathology
. 85:73-82.
1997
1993
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers
.
International Journal of Clinical and Laboratory Research
. 23:95-101.
1993
1991
Immunosuppressive effects of fish oil in normal human volunteers: Correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes
.
Clinical immunology and immunopathology
. 61:161-176.
1991
Research
Research Overview
Cystic Fibrosis, Asthma, Patient Safety, Lung inflammation
Principal Investigator On
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Assessing Effectiveness of CF Infection Prevention & Control Guidelines
awarded by
University of North Carolina at Chapel Hill
Private Grant
awarded by
CELTAXSYS, INC.
Private Grant
awarded by
ASTRAZENECA AB
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PROTEOSTASIS THERAPEUTICS, INC.
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
TDN Additional Research Coordinator
awarded by
Cystic Fibrosis Foundation ^
TDN Additional Research Coordinator
awarded by
Cystic Fibrosis Foundation ^
TDN Additional Research Coordinator (ARC)
awarded by
Cystic Fibrosis Foundation ^
TDN PI Protected Effort
awarded by
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS., INC
Investigator On
A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are Colonized with Nontuberculous Mycobacteria (The ABATE Study)
awarded by
SEATTLE CHILDREN'S HOSPITAL
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
ANDDi - American Lung Association Novel Digital Diary Trial
awarded by
American Lung Association
Airways Clinical Research Center (ACRC)
awarded by
American Lung Association
Airways Clinical Research Centers (ACRC)
awarded by
American Lung Association
Airways Clinical Research Centers (ACRC) Network
awarded by
American Lung Association
Airways Clinical Research Centers (ACRC) Network
awarded by
American Lung Association
Airways Clinical Research Centers (ALA-ACRC) Network
awarded by
American Lung Association
Airways Clinical Research Centers (ALA-ACRC) Network
awarded by
American Lung Association
Characterizing CFTR Modulated Changes in Sweat Chloride & Clinical Outcomes
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Development of Standardized Measures of Barriers to Treatment Adherence: Field Testing and Psychometric Validation
awarded by
CHILDREN'S HOSPITAL (BOSTON)
Implementation of the Depression and Anxiety Guideline: Award for a Mental Health Coordinator
awarded by
Cystic Fibrosis Foundation ^
Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma
awarded by
American Lung Association
Losartan as Anti-Inflammatory Therapy to Augment F508del CFTR Recovery
awarded by
University of Miami
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PROTEOSTASIS THERAPEUTICS, INC.
Private Grant
awarded by
INSMED PHARMACEUTICALS, INC.
Private Grant
awarded by
TRANSLATE BIO, INC ^
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PROTEOSTASIS THERAPEUTICS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
TRANSLATE BIO, INC ^
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
ELECTROMED, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
TRANSLATE BIO, INC ^
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
awarded by
SEATTLE CHILDREN'S HOSPITAL
Rare CFTR Mutation Cell Collection Protocol (RARE)
awarded by
SEATTLE CHILDREN'S HOSPITAL
Role of Body Fat Distribution in Metabolic and Pulmonary Decline in CF
awarded by
Emory University
Therapeutics Development Center Award
awarded by
Cystic Fibrosis Foundation ^
UAB CF Research and Translation Core Center
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
UAB CF Research and Translation Core Center - Core C
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Center for Care, Teaching, and Research
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Translational Development Center
awarded by
Cystic Fibrosis Foundation ^
UAB Therapeutic Development Network Center
awarded by
Cystic Fibrosis Foundation ^
Background
Education And Training
University of Florida, Internship
University of Florida, Residency
University of Florida, Postdoctoral Fellowship
Doctor of Medicine,
Medical University of South Carolina
1995
Contact
Full Name
Isabel
Virella-Lowell